Matrix Metalloproteinase Inhibitors
- Name
- Matrix Metalloproteinase Inhibitors
- Accession Number
- DBCAT001461
- Description
Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES.
- Drugs
Drug Drug Description 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide Not Available 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide Not Available Abametapir A pediculicide metalloproteinase used topically in the treatment of head lice infection. CGS-27023 Not Available Ilomastat Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor. Prinomastat Investigated for use/treatment in brain cancer, lung cancer, and prostate cancer. S-3304 S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non... - Drugs & Drug Targets